Table 3 Univariable clinical predictors of BALL ≥ 30% in patients with fibrotic hypersensitivity pneumonitis (N = 88)
Characteristic | OR (95% CI) | P value |
|---|---|---|
Age* | 0.98 (0.94–1.02) | 0.392 |
Male sex | 0.74 (0.29–1.91) | 0.542 |
Ever smoker | 0.52 (0.18–1.49) | 0.210 |
TLC%* | 1.01 (0.97–1.05) | 0.467 |
FVC%* | 1.00 (0.98–1.03) | 0.763 |
DLCO%* | 1.01 (0.97–1.04) | 0.524 |
Any positive HP serology, (excluding untested, N = 12) | 1.01 (0.36–2.83) | 0.978 |
Any identifiable exposure history (excluding those with unknown exposures, N = 38) | 1.38 (0.52–3.61) | 0.508 |
Avian | 1.58 (0.47–5.65) | 0.457 |
Mold/bacterial | 0.96 (0.25–3.38) | 0.948 |
GGO | 0.76 (0.26–2.45) | 0.638 |
Mosaic attenuation | 1.04 (0.39–2.93) | 0.927 |
Centrilobular nodules | 4.07 (1.28–12.93) | 0.018 |
Honeycombing | 6.9 × e−8 (0–1.07e−19) | 0.001 |